Cindy Perettie

Cindy Perettie

Executive Vice President and Global Head of Kite

Gilead Sciences
Bringing Business and Global Health, Cindy Perettie, Executive VP of Kite, Shares a Journey of Science and Business to Provide World-class Treatment

With a profound knowledge and interest in science, Cindy Perettie spent many of her working years learning how to apply this to roles in the corporate world. 

Her journey began with Bachelor’s of Science in Biology and a Minor in Chemistry, which allowed her to begin her pursuit of work in research and discovery. 

Her first working role as a Senior Research Associate for the Johns Hopkins University led her down a path to learn more about the business aspects of pharmaceuticals, which led to her current role as the Executive VP of Kite. However, on this path there were many steps to take as Perettie evolved to meet the needs of companies like Chiron Corporation, Genentech, Roche and Foundation Medicine

To fulfil her need for business knowledge, she later underwent a Master’s in Business Administration, which helped form her understanding of the corporate environment and how it aligns with global health and sustainability. 

The key challenges of her current role are twofold as Perettie not only has to engage in commercial activities, but do so without compromising the core mission of delivering treatment to lymphoma patients in the fastest time possible. 

“As a head of a company, there's the challenges of balancing delivery on the business side while ensuring we continue to engage employees and really do what's right, not just for patients but for society,” says Perettie. 

In terms of her role at Kite, she says: “We have been focused on delivering our CAR T therapy, not just at academic medical centres but also closer to where patients live in the community—and that's been a challenge that we’ve tackled over the course of the last year.”

Truly driven by the end goal of Kite, Perettie attributes her greatest inspiration to the patients that she and Kite. The criticality of their illnesses and their ability to tackle their diseases head-on is what makes her want to get to work harder and ensure the best outcomes for them. 

“It requires resilience, so be in it for the long game.”

Read the full story HERE.

Make sure you check out the latest edition of Sustainability Magazine and also sign up to our global conference series - Sustainability LIVE 2024

**************

Sustainability Magazine is a BizClik brand

Gilead Sciences (Kite Pharma)
Gilead Sciences (Kite Pharma)
Share

Featured Interviews

Featured

Kevin Dunckley

CSO at HH Global

Kevin Dunckley, CSO at HH Global, tells why he has a ‘spring in his step’ as he drives sustainability for the company, its clients and their suppliers

Read More

Chris Shanahan

VP Global Sustainability Supply Chain

Chris Shanahan, Alyssa Caddle and Matthew Yamatin lead procurement and supply chain sustainability at Thermo Fisher Scientific

Read More
“Every time you come across a challenge, that's an opportunity to improve,”
Chris Shanahan
VP Global Sustainability Supply Chain

Danielle Rossi

Global Director of Data Centres at Trane

Trane’s Global Director for Data Centres Danielle Rossi

Read More

Mark Jones

Chief Sustainability Officer at THG

Mark Jones, Chief Sustainability Officer at THG, on how the global ecommerce leader is making a positive impact in the realm of sustainability

Read More

Chad Wilkerson

Director, Sustainability & Infrastructure Sourcing at T-Mobile

Chad Wilkerson, Director, Sustainability at T-Mobile, shares how the company is reducing its impact on the environment, and the suppliers that contribute

Read More

Kevin Dunckley

CSO at HH Global

Kevin Dunckley, CSO at HH Global, tells why he has a ‘spring in his step’ as he drives sustainability for the company, its clients and their suppliers

Read More